Evaluation of the Immunogenicity and Impact on the Latent HIV-1 Reservoir of an HIV Conserved Region Vaccine, MVA.HIVconsv, in HAART-treated Subjects

Abstract

AIDS Research and Human RetrovirusesVol. 30, No. S1 Vaccine Clinical TrialsEvaluation of the Immunogenicity and Impact on the Latent HIV-1 Reservoir of an HIV Conserved Region Vaccine, MVA.HIVconsv, in HAART-treated SubjectsSara Morón-López, Gemma Hancock, Maria Carmen Puertas, Annie Rose, Maria Salgado, Emma-Jo Hayton, Catharine Morgan, Brian Angus, Hongbing Yang, Tomas Hanke, Lucy Dorrell, and Javier Martinez-PicadoSara Morón-LópezAIDS Research Institute IrsiCaixa, Badalona, SpainSearch for more papers by this author, Gemma HancockOxford NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomSearch for more papers by this author, Maria Carmen PuertasAIDS Research Institute IrsiCaixa, Badalona, SpainSearch for more papers by this author, Annie RoseOxford NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomSearch for more papers by this author, Maria SalgadoAIDS Research Institute IrsiCaixa, Badalona, SpainSearch for more papers by this author, Emma-Jo HaytonOxford NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomSearch for more papers by this author, Catharine MorganGenitourinary Medicine, Oxford University Hospitals NHS Trust, Oxford, United KingdomSearch for more papers by this author, Brian AngusOxford NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomSearch for more papers by this author, Hongbing YangOxford NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomSearch for more papers by this author, Tomas HankeOxford NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomSearch for more papers by this author, Lucy DorrellOxford NIHR Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, United KingdomGenitourinary Medicine, Oxford University Hospitals NHS Trust, Oxford, United KingdomSearch for more papers by this author, and Javier Martinez-PicadoAIDS Research Institute IrsiCaixa, Badalona, SpainICREA, Barcelona, SpainSearch for more papers by this authorPublished Online:30 Oct 2014https://doi.org/10.1089/aid.2014.5407.abstractAboutSectionsView articleView Full TextPDF/EPUB ToolsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View article"Evaluation of the Immunogenicity and Impact on the Latent HIV-1 Reservoir of an HIV Conserved Region Vaccine, MVA.HIVconsv, in HAART-treated Subjects." AIDS Research and Human Retroviruses, 30(S1), p. A190FiguresReferencesRelatedDetails Volume 30Issue S1Oct 2014 InformationCopyright 2014, Mary Ann Liebert, Inc.To cite this article:Sara Morón-López, Gemma Hancock, Maria Carmen Puertas, Annie Rose, Maria Salgado, Emma-Jo Hayton, Catharine Morgan, Brian Angus, Hongbing Yang, Tomas Hanke, Lucy Dorrell, and Javier Martinez-Picado.Evaluation of the Immunogenicity and Impact on the Latent HIV-1 Reservoir of an HIV Conserved Region Vaccine, MVA.HIVconsv, in HAART-treated Subjects.AIDS Research and Human Retroviruses.Oct 2014.A190-A190.http://doi.org/10.1089/aid.2014.5407.abstractPublished in Volume: 30 Issue S1: October 30, 2014PDF download